FDA Accepts Resubmission for RP1 Oncolytic Immunotherapy Plus Nivolumab in PD-1–Refractory Melanoma

FDA Accepts Resubmission for RP1 Oncolytic Immunotherapy Plus Nivolumab in PD-1–Refractory Melanoma

OncoDaily Party Berlin 2025: A Night Where Oncology Met Energy

OncoDaily Party Berlin 2025 ESMO

100 Influential People in Oncology 2025 - Nominations are Open!

100 Influential People in Oncology 2025

Iza-bren (EGFR×HER3 bispecific ADC) 303 Study: Late-breaking ESMO presentation, The Lancet publication, and press-conference Q&A highlights

iza-bren egfrxher3 bispecific press release

Zihai Li: First-In-Human Anti-GARP CAR-T Trial for Patients With Relapsed GBM

Zihai Li

Enrique Soto: New ASCO Global Guideline on Geriatric Assessment

Enrique Soto

International Cardio-Oncology Society Introduced the GCOS 2025 Social Media Ambassador Team

International Cardio-Oncology Society Introduced the GCOS 2025 Social Media Ambassador Team

Katy Rezvani: Comprehensive Overview of Engineered Natural Killer Cells for Cancer Therapy

Katy Rezvani

OncoCalendar

« All Events

Virtual Event
  • This event has passed.

International Lung Cancer Survivorship Conference (ILCSC) 2025

Sep 26 - Sep 27
Virtual Event
Lung Cancer Survivorship

The International Lung Cancer Survivorship Conference (ILCSC) 2025 is a free virtual event, organized by LUNGevity Foundation, scheduled for September 26-27, 2025, designed for lung cancer patients, caregivers, and advocates.

It offers expert-led sessions on the latest advances in lung cancer treatment, survivorship, and research, with opportunities to connect with specialists and hear inspiring survivor stories. The conference is accessible worldwide with just an internet connection and aims to empower attendees with knowledge and support in lung cancer care.

Details

Start:
Sep 26
End:
Sep 27
Website:
https://reg.eventmobi.com/ilcsc2025

Organizer

LUNGevity Foundation
Email
info@lungevity.org
View Organizer Website